Creating a Mouse Model for Retinoic Acid-Resistant Acute Promyelocytic Leukaemia
Author Information
Author(s): Y Fukuchi, M Kizaki, K Kinjo, N Awaya, A Muto, M Ito, Y Kawai, A Umezawa, J Hata, Y Ueyama, Y Ikeda
Primary Institution: Keio University School of Medicine
Hypothesis
Can a human retinoic acid-resistant APL model be established in SCID mice?
Conclusion
The study successfully established the first human retinoic acid-resistant APL model in SCID mice, which can be used for further research on APL and potential therapies.
Supporting Evidence
- UF-1 cells formed tumors in all hGMTg SCID mice but not in control mice.
- Single-cell suspensions from tumors showed similar features to parental UF-1 cells.
- All-trans retinoic acid did not change the growth or differentiation of UF-1 cells.
Takeaway
Researchers made a special type of mouse that can help us understand a kind of blood cancer that doesn't respond to a common treatment.
Methodology
The study involved transplanting a retinoic acid-resistant APL cell line into transgenic SCID mice and assessing tumor formation and characteristics.
Limitations
The model may not fully replicate human APL conditions due to the differences between species.
Want to read the original?
Access the complete publication on the publisher's website